Metastatic breast cancer trials in Peru

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

  Where

  Concepción, San Borja, San Isidro

  Age

  18 years and over

  People

  1,000 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07060807 · EU 2025-520582-51-00
• Phase 3Taking people
  Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

  Where

  Bellavista, Jesus Maria, Lima, Lima

  Age

  18 years and over

  People

  788 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06380751 · EU 2023-504180-16-00
• Phase 3Taking people
  A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

  Where

  Arequipa, Jesús María, Lima

  Age

  18 years and over

  People

  1,200 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06312176 · EU 2023-504918-29-00